Capricor Therapeutics Inc. (CAPR) 7.7000 $CAPR Capricor

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Capricor Therapeutics Inc. (CAPR) 7.7000 $CAPR

Capricor Therapeutics to Present ALLSTAR Phase I Trial Data at ACC Annual Meeting 2014
GlobeNewswire - Fri Mar 28, 12:42PM CDT
Capricor Therapeutics, Inc. (OTCBB:CAPR), a biotechnology company focused on developing novel therapeutics to prevent and treat heart disease, today announced Co-founder and Scientific Advisory Board Chairman, Dr. Eduardo Marbán, M.D., Ph.D., will present at the American College of Cardiology 63 Annual Scientific Session and Expo, taking place March 29-31, 2014 in Washington, DC. Dr. Marbán's presentation will highlight positive data demonstrating that the Phase I portion of the Company's ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR) Phase I/II trial met its primary endpoint of safety.

Capricor Therapeutics to Present at Two Upcoming Investor Conferences
GlobeNewswire - Mon Mar 10, 1:11PM CDT
Capricor Therapeutics, Inc. (OTCBB:CAPR) today announced that Chief Executive Officer Dr. Linda Marbán is scheduled to present at the 26 Annual ROTH Conference, being held March 9-12, 2014 in Dana Point, Calif., and the Alliance for Regenerative Medicine's 2 Annual Regen Med Investor Day on March 26, 2014 in New York, N.Y.

Capricor Therapeutics and Janssen Biotech, Inc. Enter Into Collaboration Agreement and Exclusive License Option
GlobeNewswire - Mon Jan 06, 7:30AM CST
Capricor Therapeutics, Inc. (OTCBB:CAPR) today announced that it has executed a collaboration agreement and exclusive license option with Janssen Biotech, Inc. (Janssen). Under the terms of the agreement, Capricor and Janssen agreed to collaborate on the development of Capricor's cell therapy program for cardiovascular applications, including its lead product, CAP-1002. CAP-1002 is an allogeneic cardiosphere-derived cell (CDC) therapeutic under evaluation in patients who have suffered a large myocardial infarction. Pursuant to the agreement, Capricor and Janssen will collaborate on elements of cell manufacturing development. Capricor will contribute to the costs of the manufacturing collaboration, and will receive an upfront payment of $12.5 million from Janssen.

Capricor Therapeutics Announces Ticker Symbol Change to CAPR
Business Wire - Fri Dec 20, 5:00AM CST
Capricor Therapeutics, Inc. (OTCBB: CAPR), a diversified heart failure biotechnology company, today announced that, effective today, the Company's common stock commences trading on the OTC Markets under the new symbol "CAPR." The previous trading symbol was "NLTXD." The ticker symbol change follows the recently completed merger between Capricor, Inc. and Nile Therapeutics, Inc.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rachel Noble Joins AGS: Signals Strategy Shift

Updated Category News Views 92

A Tactical Addition to American Global Strategies The chessboard of global security just saw a savvy new player join American Global Strategies (AGS). Rachel Noble, a name that echoes through the halls of Australia's national security apparatus, has joined AGS as Senior Advisor. This isn't your garden-variety hire—this is a strategic power move. From Down Under to the...

Continue Reading
Boosting Employability: English Skills in Italy's Job Market

Updated Category News Views 95

Tackling Language Barriers in Italy's Workforce If you're looking to make it big in Italy, you're facing a task that demands more than just regional expertise. The working world is no longer bound by borders, and for Italians eyeing international gigs, English fluency is a must-have. While not an absolute ticket to success, grasping English could be your career's booster...

Continue Reading
Third Lake Parts Ways with WaterView Retail Center

Updated Category News Views 55

Third Lake Partners Exits WaterView Retail in Florida Alright, you don't stumble across deals like this every day. Third Lake Partners just tossed the keys to their WaterView Retail Center in St. Petersburg, wrapping up the retail and residential parts under one roof with Walton Street Capital. It only took a cool five years since its completion in 2021, but hey, better...

Continue Reading
Longevity Tour Hits East Coast: Brecka's Mission

Updated Category News Views 94

Bringing Longevity to the East Coast This weekend, something interesting is happening on the East Coast of the U.S. Gary Brecka and his Ultimate Longevity Center (ULC) are holding a series of events in Philadelphia, New York, and Boston. Everything kicks off on November 14th. If the idea of 'live longevity' leaves you scratching your head, don’t worry—I've got you...

Continue Reading
Abbisko's PIMJETMI® Gains FDA Nod, Boosting TGCT Treatment

Updated Category News Views 35

PIMJETMI® Scores FDA Approval, Expanding Global Reach Well, here's something to chew on over your morning coffee—PIMJETMI® (pimicotinib) just snagged the U.S. FDA's blessing to treat tenosynovial giant cell tumor (TGCT), making it another notch on Abbisko Therapeutics' belt. This approval is a strategic home run for Abbisko and their pals at Merck KGaA, Darmstadt,...

Continue Reading
Creative Solutions Joins FICO Marketplace, Boosts AI Edge

Updated Category News Views 78

Creative Solutions and FICO Unite Well, we're diving into some strategic magic today. Creative Solutions International, not just your average marketing agency, has just hopped onto the FICO Marketplace platform. The word on the street is they're shaking things up with their Collections Marketing Platform. It's like giving your old financial letters a whole AI-driven paint...

Continue Reading
Envista's $430M Senior Notes: A Market Move Decoded

Updated Category News Views 97

Envista on the Move with $430M Notes Ever feel like the market's a bit like a rollercoaster with no brakes? That's kind of where we're at with Envista Holdings Corporation (NYSE: NVST) rolling out this new financial play. They just priced a hefty $430 million in Senior Notes at a solid 6.250% due 2033. In terms of the investment world, that's a pretty big splash. The...

Continue Reading
McEwen Faces Investigation Amid Declining Production

Updated Category News Views 35

MUX Investors on Alert as Legal Stakes Rise The gold mining world isn't exactly flooded with excitement these days, and McEwen Inc.'s (NYSE: MUX) latest dealings ain't doing much to brighten up the scenery. When their third-quarter gold output took a nosedive—a 23% drop to be exact—it caught more eyes than a bull market will. Production Guidance in Question Now,...

Continue Reading
Kemin Unveils LYSOFORTE ENFUSIO at EuroTier 2026

Updated Category News Views 158

Rollin' up to EuroTier 2026 with all its buzz—a place where big players in livestock production flex their muscles—Kemin Industries dropped a new ace in the feed deck: LYSOFORTE ENFUSIO. They're betting this bad boy will shake things up for poultry and pig nutritionists looking to maximize what's already on their plate without piling on more grain or feed costs....

Continue Reading
A Gentle Stake: Colts Neck's Rural Fight Ahead

Updated Category News Views 101

Michael Fazio's Gambit in Colts Neck If you're not fired up about land deals, you should be now. Michael Fazio, the owner of Synergy Stables in Colts Neck, New Jersey, is laying his cards on the table with a proposition for preserving the integrity of the township's rural landscape. Rather than cashing in on monstrous offers for high-density housing, Fazio's plan involves...

Continue Reading

Top 5 Most Recently Viewed Articles

Legal Investigation Underway for Investors of Xiao-I Corporation

Updated Category News Views 249

Faruqi & Faruqi, LLP Investigates Potential Claims for Investors Faruqi & Faruqi, LLP is taking a closer look at the recent financial struggles of Xiao-I Corporation. This is particularly important for investors who have incurred losses exceeding $50,000. If you fall within this category, it may be beneficial to reach out to their dedicated securities litigation partner,...

Continue Reading
Simmons First National Corporation: Transitioning Leadership Ahead

Updated Category News Views 126

Simmons First National Corporation Leadership Changes Simmons First National Corporation (NASDAQ: SFNC) has recently announced a significant change in its leadership structure. This decision marks a vital transition for the company as it prepares for the next chapter of its growth and development. Retirement Announcement of George Makris, Jr. After an impressive tenure,...

Continue Reading
Citi's Investment Strategy: Navigating the 2025 Market Landscape

Updated Category News Views 1295

Citi's Outlook for 2025: Sector Foresight Analysts at Citi have recently shared insights into their equity strategy for the upcoming year, outlining a balanced approach as investors navigate various macroeconomic factors and uncertainties in policy. Their comprehensive strategy, referred to as the "SIGN (Sector & Industry Group Navigator)," focuses on several key sectors...

Continue Reading
Insights on O3 Mining's Marban Alliance Economic Progress

Updated Category News Views 96

Updates on O3 Mining's Marban Alliance Project O3 Mining Inc. (TSXV: OIII | OTCQX: OIIIF) has announced a significant move forward in its flagship Marban Alliance project. The company has engaged G Mining Services Inc. to conduct a preliminary economic assessment (PEA) designed to refine the strategies for this promising gold-mining venture. With results anticipated in...

Continue Reading
Revving Up Vehicle Innovation: Sonatus at CES 2025

Updated Category News Views 539

Groundbreaking Innovations in Software-Defined Vehicles At CES 2025, Sonatus, a global trailblazer in software-defined vehicle (SDV) technologies, unveiled a remarkable array of products and solutions aimed at empowering original equipment manufacturers (OEMs) to unlock the potential of SDVs. The highlights included transformative contributions from Generative AI that...

Continue Reading